
    
      OBJECTIVES: I. Find the best pattern for response evaluation for gastric cancer. II. Assess
      the factor associated with this pattern.

      OUTLINE: Neoadjuvant chemotherapy.

      PROJECTED ACCRUAL: Up to 150 patients will be accrued over approximately 2 years.
    
  